More news

Contact us

Market analysis of China's traditional Chinese medicine industry in 2020: the market size has exceeded 800 billion yuan, and the cardiovascular and cerebrovascular market is relatively large.

Keywords: Chinese medicine sulfur dioxide tester Chinese Pharmacopoeia 2020


1. Chinese residents’ health awareness has increased
 
After experiencing outbreaks of various diseases such as avian flu, swine flu and various infectious diseases, Chinese residents pay more attention to health and are willing to spend more on Chinese medicine and other medical and health products to maintain and improve their health. China's per capita annual consumption expenditure on health/medical products and services increased from approximately RMB1,165 in 2015 to approximately RMB1,902 in 2019, with a compound annual growth rate of approximately 13.0%.
2015-2019年中国保健╱医疗产品及服务人均年消费开支统计及增长情况

2. China’s traditional Chinese medicine market is growing rapidly
 
In recent years, the government has introduced a series of measures to reform the medical system, stimulating the development of China's pharmaceutical industry. China's traditional Chinese medicine market experienced rapid growth between 2015 and 2019, with the market size increasing from 625.2 billion yuan in 2015 to 814.9 billion yuan in 2019, with a compound annual growth rate of 6.8%.
 

2015-2019年中国中成药行业市场规模统计情况

In 2019, my country's output of traditional Chinese medicine was 2.464 million tons. As of January-September 2020, China's output of traditional Chinese medicine reached 1.584 million tons, a year-on-year decrease of 11.5%.

2016-2020年前9月中国中成药产量统计情况

The market size of China's QDBS traditional Chinese medicine (traditional Chinese medicine pills for replenishing qi and blood) increased from approximately RMB 51.4 billion in 2014 to approximately RMB 92.9 billion in 2019, with a compound annual growth rate of 12.6%.
2015-2019年中国QDBS中成药行业市场规模(按销售额)统计及增长情况

Note: The market size grew at a rate of 13.5% in 2015.
 
According to the China Cardiovascular Disease Report 2018, the number of patients with cardiovascular and cerebrovascular diseases in China may reach 290 million, and the number of patients is estimated to continue to rise by more than 30% in the next decade. The market size of CC Chinese patent medicine (cardiovascular and cerebrovascular Chinese patent medicine capsules) has increased from approximately RMB 135.9 billion in 2014 to approximately RMB 225.4 billion in 2019, with a compound annual growth rate of 10.6%.
 

2015-2019年中国CC中成药行业市场规模(按销售额)统计及增长情况

For the above data and analysis, please refer to the "China Traditional Chinese Medicine Industry Market Demand and Investment Forecast Analysis Report" of the Forward-looking Industry Research Institute. At the same time, the Forward-looking Industry Research Institute provides solutions such as industrial big data, industrial planning, industrial declaration, industrial park planning, and industrial investment attraction.


Article link: Chemical Instrument Network http://www.chem17.com/news/detail/130715.html
Previous article:已经是第一页了
Next article:已经是最后一页了